Pharmaceuticals news FT.com

AstraZeneca sales jump despite troubles in China

FTSE’s most valuable company faces potential fine over suspected unpaid taxes in country

Feb 9, 2025 - 22:26
 0
AstraZeneca sales jump despite troubles in China
FTSE’s most valuable company faces potential fine over suspected unpaid taxes in country
Read More

Tags:

Previous Article

Eli Lilly expects to beat profit forecasts on obesity drug demand

Next Article

Obesity drug sales surge at Novo Nordisk

Related Posts

Manchester looks to build on life sciences cluster effect

Manchester looks to build on life sciences cluster effect

Mar 10, 2025  0

Novo Nordisk shares fall on latest trial results for new obesity drug

Novo Nordisk shares fall on latest trial results for ne...

Mar 10, 2025  0

What went wrong after Walgreens bought Boots?

What went wrong after Walgreens bought Boots?

Feb 28, 2025  0